| Lastest Insider Transactions Of Maze Therapeutics, Inc. ( MAZE ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-09-04 | Sell | 9,705 | 26.22 | 254,502 | 2026-09-08 16:20:35 |
| MAZE | Maze Therapeutics, Inc. | Courtney Phillips | GC and Corp. Secretary | 2026-09-02 | Sell | 3,993 | 26.24 | 104,766 | 2026-09-04 16:27:14 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-09-02 | Sell | 6,434 | 26.24 | 168,811 | 2026-09-04 16:25:49 |
| MAZE | Maze Therapeutics, Inc. | Coloma Jason V | Chief Executive Officer | 2026-09-02 | Sell | 22,638 | 26.24 | 593,955 | 2026-09-04 16:24:27 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-09-02 | Sell | 10,295 | 26.24 | 270,111 | 2026-09-04 16:22:03 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-08-28 | Sell | 7,500 | 27.58 | 206,824 | 2026-08-31 18:32:29 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-08-28 | Option Exercise | 7,500 | 10.42 | 78,150 | 2026-08-31 18:32:29 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-08-13 | Sell | 16,142 | 27.61 | 445,621 | 2026-08-14 16:54:48 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-08-13 | Option Exercise | 16,142 | 10.42 | 168,200 | 2026-08-14 16:54:48 |
| MAZE | Maze Therapeutics, Inc. | Coloma Jason V | Chief Executive Officer | 2026-08-03 | Sell | 34,501 | 26.73 | 922,315 | 2026-08-05 16:08:58 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-07-29 | Sell | 7,500 | 27.34 | 205,031 | 2026-07-31 16:15:20 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-07-29 | Option Exercise | 7,500 | 10.42 | 78,150 | 2026-07-31 16:15:20 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-07-01 | Sell | 14,609 | 29.90 | 436,864 | 2026-07-02 16:29:57 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-07-01 | Option Exercise | 14,609 | 10.42 | 152,226 | 2026-07-02 16:29:57 |
| MAZE | Maze Therapeutics, Inc. | Coloma Jason V | Chief Executive Officer | 2026-07-01 | Sell | 34,501 | 29.98 | 1,034,253 | 2026-07-02 16:28:41 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-06-29 | Sell | 7,500 | 28.02 | 210,150 | 2026-07-01 16:17:19 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-06-29 | Option Exercise | 7,500 | 10.42 | 78,150 | 2026-07-01 16:17:19 |
| MAZE | Maze Therapeutics, Inc. | Coloma Jason V | Chief Executive Officer | 2026-06-22 | Sell | 27,858 | 26.04 | 725,495 | 2026-06-24 16:14:54 |
| MAZE | Maze Therapeutics, Inc. | Coloma Jason V | Chief Executive Officer | 2026-06-01 | Sell | 6,643 | 26.20 | 174,048 | 2026-06-03 17:04:16 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-06-01 | Sell | 14,853 | 25.66 | 381,112 | 2026-06-03 17:01:37 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-06-01 | Option Exercise | 14,853 | 10.42 | 154,768 | 2026-06-03 17:01:37 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-05-29 | Sell | 7,500 | 26.34 | 197,554 | 2026-06-02 16:12:07 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-05-29 | Option Exercise | 7,500 | 10.42 | 78,150 | 2026-06-02 16:12:07 |
| MAZE | Maze Therapeutics, Inc. | Coloma Jason V | Chief Executive Officer | 2026-05-22 | Sell | 32,564 | 26.01 | 847,048 | 2026-05-27 16:16:23 |
| MAZE | Maze Therapeutics, Inc. | Coloma Jason V | Chief Executive Officer | 2026-05-15 | Sell | 1,938 | 26.00 | 50,388 | 2026-05-18 17:07:29 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-05-14 | Sell | 15,000 | 26.22 | 393,354 | 2026-05-18 17:03:49 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-05-14 | Option Exercise | 15,000 | 10.42 | 156,300 | 2026-05-18 17:03:49 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-05-04 | Option Exercise | 14,305 | 10.42 | 149,058 | 2026-05-06 16:15:49 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-04-29 | Sell | 7,500 | 25.37 | 190,299 | 2026-05-01 16:18:22 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-04-29 | Option Exercise | 7,500 | 10.42 | 78,150 | 2026-05-01 16:18:22 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-04-01 | Sell | 15,000 | 29.46 | 441,904 | 2026-04-02 16:08:21 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-04-01 | Option Exercise | 15,000 | 10.42 | 156,300 | 2026-04-02 16:08:21 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2026-04-01 | Sell | 2,500 | 29.44 | 73,611 | 2026-04-02 16:06:49 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2026-04-01 | Option Exercise | 2,500 | 10.42 | 26,050 | 2026-04-02 16:06:49 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-03-30 | Sell | 7,500 | 29.34 | 220,019 | 2026-04-01 16:12:33 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-03-30 | Option Exercise | 7,500 | 10.42 | 78,150 | 2026-04-01 16:12:33 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-03-20 | Sell | 15,000 | 49.10 | 736,439 | 2026-03-20 18:50:07 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-03-20 | Option Exercise | 15,000 | 10.42 | 156,300 | 2026-03-20 18:50:07 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-03-10 | Sell | 30,000 | 50.45 | 1,513,560 | 2026-03-12 16:51:12 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-03-10 | Option Exercise | 30,000 | 10.42 | 312,600 | 2026-03-12 16:51:12 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-02-02 | Sell | 15,000 | 46.02 | 690,334 | 2026-02-04 16:25:47 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-02-02 | Option Exercise | 15,000 | 10.42 | 156,300 | 2026-02-04 16:25:47 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2026-02-02 | Sell | 5,000 | 46.04 | 230,219 | 2026-02-04 16:23:11 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2026-02-02 | Option Exercise | 5,000 | 10.42 | 52,100 | 2026-02-04 16:23:11 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-01-29 | Sell | 7,500 | 44.27 | 331,990 | 2026-02-02 16:21:38 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2026-01-29 | Option Exercise | 7,500 | 10.42 | 78,150 | 2026-02-02 16:21:38 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2026-01-22 | Sell | 5,000 | 45.52 | 227,612 | 2026-01-26 16:10:37 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2026-01-22 | Option Exercise | 5,000 | 10.42 | 52,100 | 2026-01-26 16:10:37 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-01-07 | Sell | 25,156 | 40.20 | 1,011,299 | 2026-01-09 16:51:26 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-01-07 | Option Exercise | 25,156 | 10.42 | 262,126 | 2026-01-09 16:51:26 |
| MAZE | Maze Therapeutics, Inc. | Sohn Catherine A. | Directior | 2026-01-06 | Option Exercise | 29,413 | 10.42 | 306,483 | 2026-01-08 16:30:38 |
| MAZE | Maze Therapeutics, Inc. | Sohn Catherine A. | Directior | 2026-01-06 | Sell | 29,413 | 39.07 | 1,149,054 | 2026-01-08 16:30:38 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-01-02 | Sell | 4,844 | 40.39 | 195,668 | 2026-01-06 16:31:52 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2026-01-02 | Option Exercise | 4,844 | 10.42 | 50,474 | 2026-01-06 16:31:52 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2025-12-29 | Sell | 72,500 | 40.56 | 2,940,800 | 2025-12-31 16:24:23 |
| MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | 2025-12-29 | Option Exercise | 72,500 | 10.42 | 755,450 | 2025-12-31 16:24:23 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2025-12-29 | Sell | 45,000 | 40.56 | 1,825,355 | 2025-12-31 16:22:36 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2025-12-29 | Option Exercise | 45,000 | 10.42 | 468,900 | 2025-12-31 16:22:36 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2025-12-29 | Sell | 45,000 | 40.56 | 1,825,355 | 2025-12-31 16:22:36 |
| MAZE | Maze Therapeutics, Inc. | Bernstein Harold | President, R&D & CMO | 2025-12-29 | Option Exercise | 45,000 | 10.42 | 468,900 | 2025-12-31 16:22:36 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2025-12-29 | Sell | 15,000 | 40.41 | 606,173 | 2025-12-31 16:20:07 |
| MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | 2025-12-29 | Option Exercise | 15,000 | 10.42 | 156,300 | 2025-12-31 16:20:07 |
| MAZE | Maze Therapeutics, Inc. | SCHELLER RICHARD H | Directior | 2025-09-15 | Sell | 20,744 | 22.37 | 464,035 | 2025-09-16 16:26:27 |
